PET imaging of atherosclerosis can quantify several in vivo pathological processes
occurring within the arterial system. 18F-fluorodeoxyglucose (FDG) is the most-commonly …

Atherosclerosis is a leading cause of morbidity and mortality. It is now widely recognized that
the disease is more than simply a flow-limiting process and that the atheromatous plaque …

Abstract Purpose 18 F-Fluorodeoxyglucose (FDG) positron emission tomography (PET)/CT
has the potential to track vascular inflammation and monitor therapeutic response. The …

OBJECTIVE Advanced glycation end products (AGEs) evoke inflammatory reactions,
contributing to the development and progression of atherosclerosis. We investigated the …

Background Age-related diseases, including cardiovascular diseases (CVD) may be
stimulated by microinflammation, marked by increased level of IL-6 and high-sensitivity CRP …

Molecular imaging seeks to unravel critical molecular and cellular events in living subjects
by providing complementary biological information to current structural clinical imaging …

Abstract 18F-FDG PET is a new noninvasive tool for inflammation functional imaging. Low
spatial resolution is now compensated by coregistration with CT or MRI. New mechanistic …

Clinically, adaptive RV hypertrophy is characterized by preservation of relatively normal
cardiac output, ejection fraction, RV filling pressure, and exercise capacity. Pathologically …

Objectives: This study sought to longitudinally investigate the relationship between a broad
spectrum of serum inflammatory biomarkers and plaque inflammation assessed by 18F …

Background There are many studies on high-sensitivity C-reactive protein (hs-CRP)
association with cardiovascular disease (CVD); however, just a few studies investigated …